208 related articles for article (PubMed ID: 30019928)
21. Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.
Zhang K; Zhao S; Wang Q; Yang HS; Zhu J; Ma R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S536-44. PubMed ID: 25976861
[TBL] [Abstract][Full Text] [Related]
22. Statistical Methods for Identifying Biomarkers from miRNA Profiles of Cancers.
Namkung J
Methods Mol Biol; 2019; 1882():261-286. PubMed ID: 30378062
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
Asiaf A; Ahmad ST; Arjumand W; Zargar MA
Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
To KK; Tong CW; Wu M; Cho WC
World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
[TBL] [Abstract][Full Text] [Related]
25. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability.
Naser Al Deen N; Nassar F; Nasr R; Talhouk R
Adv Exp Med Biol; 2019; 1152():335-364. PubMed ID: 31456193
[TBL] [Abstract][Full Text] [Related]
26. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
29. An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer.
Zhou X; Wang X; Huang Z; Xu L; Zhu W; Liu P
J Exp Clin Cancer Res; 2014 Nov; 33(1):94. PubMed ID: 25373603
[TBL] [Abstract][Full Text] [Related]
30. microRNAs as novel epigenetic biomarkers for human cancer.
Cortés-Sempere M; Ibáñez de Cáceres I
Clin Transl Oncol; 2011 Jun; 13(6):357-62. PubMed ID: 21680295
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs in breast cancer pathogenesis.
Götte M
Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
[TBL] [Abstract][Full Text] [Related]
32. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
[TBL] [Abstract][Full Text] [Related]
33. The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.
Teoh SL; Das S
Curr Pharm Des; 2017; 23(12):1845-1859. PubMed ID: 28231756
[TBL] [Abstract][Full Text] [Related]
34. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
Li D; Xia H; Li ZY; Hua L; Li L
Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
[TBL] [Abstract][Full Text] [Related]
35. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
[TBL] [Abstract][Full Text] [Related]
36. Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis.
Jordan-Alejandre E; Campos-Parra AD; Castro-López DL; Silva-Cázares MB
Cells; 2023 Feb; 12(4):. PubMed ID: 36831192
[TBL] [Abstract][Full Text] [Related]
37. Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study.
Schrijver WA; van Diest PJ; ; Moelans CB
Oncotarget; 2017 Jan; 8(2):3111-3123. PubMed ID: 27902972
[TBL] [Abstract][Full Text] [Related]
38. Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.
Sempere LF
Expert Rev Mol Diagn; 2011 Nov; 11(8):813-27. PubMed ID: 22022944
[TBL] [Abstract][Full Text] [Related]
39. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
40. Identifying significant microRNA-mRNA pairs associated with breast cancer subtypes.
Bhattacharyya M; Nath J; Bandyopadhyay S
Mol Biol Rep; 2016 Jul; 43(7):591-9. PubMed ID: 27245063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
